Trials / Completed
CompletedNCT00729300
A Study of the Relationship Between Disulfiram and Cocaine Self-administration.
Laboratory Models of Cocaine Self-administration
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Baylor College of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The problem of cocaine dependence remains a major medical, social, and legal concern. Several studies have suggested that disulfiram may be beneficial for the treatment of cocaine dependence. A common assumption has been that disulfiram treatment, by increasing DA availability, enhances the aversive aspects of stimulants. This study aims to measure plasma activity in those with the C/C DBH genotype, which is associated with higher DBH activity subsequently making the disulfiram treatment more effective, as well as determine the effects of treatment with disulfiram on cocaine self-administration using a human laboratory model of cocaine self-administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | placebo | 0mg daily |
| DRUG | disulfiram | 250mg daily |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2008-08-07
- Last updated
- 2023-07-19
- Results posted
- 2023-07-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00729300. Inclusion in this directory is not an endorsement.